RxDoctor Payments DataLook up a doctor →

LYNPARZA: payments to doctors

Payments that named LYNPARZA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$22.5M
Providers
25,876
Transactions
142,834
Average per transaction
$157

The per-transaction average — $157 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 25,876 providers the average total is $869, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
AstraZeneca$18,445,60382.1%
Merck$3,260,66814.5%
Astrazeneca UK Limited$758,6053.4%
Acerta Pharma LLC$11,0120.0%
← All drugs & devices